KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
0.115
-0.005 (-4.10%)
At close: Apr 28, 2026, 4:00 PM EDT
0.115
+0.000 (0.26%)
After-hours: Apr 28, 2026, 7:57 PM EDT
KALA BIO Market Cap
KALA BIO has a market cap or net worth of $106.43 million as of April 28, 2026. Its market cap has increased by 381.57% in one year.
Market Cap
106.43M
Enterprise Value
98.87M
1-Year Change
381.57%
Ranking
Category
Stock Price
$0.11
Market Cap Chart
Since July 20, 2017, KALA BIO's market cap has decreased from $430.50M to $106.43M, a decrease of -75.28%. That is a compound annual growth rate of -14.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 110.60M | 2,304.35% |
| Dec 31, 2025 | 4.60M | -85.63% |
| Dec 31, 2024 | 32.00M | 69.31% |
| Dec 29, 2023 | 18.90M | -67.36% |
| Dec 30, 2022 | 57.90M | -26.99% |
| Dec 31, 2021 | 79.30M | -79.14% |
| Dec 31, 2020 | 380.20M | 198.20% |
| Dec 31, 2019 | 127.50M | -22.87% |
| Dec 31, 2018 | 165.30M | -63.54% |
| Dec 29, 2017 | 453.40M | 5.32% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Verrica Pharmaceuticals | 117.25M |
| InflaRx | 116.39M |
| NeOnc Technologies Holdings | 114.84M |
| Cognition Therapeutics | 114.37M |
| Genelux | 113.82M |
| Cibus | 113.66M |
| Oncolytics Biotech | 112.49M |
| PepGen | 110.58M |